Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Institute for Systems Biology

Founders Alan Aderem Leroy Hood Ruedi Aebersold



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
The average size of a deal this fund participated in
Portfolio companies 2
Rounds per year 0.14
Lead investments 0
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees Soon

Areas of investment

  • Venture Capital
  • Finance
  • Banking
  • Biotechnology
  • Health Care

In 2000 was created Institute for Systems Biology, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Seattle.

Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Theraclone Sciences. Among the most successful fund investment fields, there are Medical, Biotechnology.

The top activity for fund was in 2006. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year.

The typical case for the fund is to invest in rounds with 5 participants. Despite the Institute for Systems Biology, startups are often financed by Versant Ventures, MPM Capital, Alexandria Real Estate Equities. The meaningful sponsors for the fund in investment in the same round are ARCH Venture Partners, Versant Ventures, MPM Capital. In the next rounds fund is usually obtained by Amgen Ventures, Alexandria Real Estate Equities, ARCH Venture Partners.

This organization was formed by Leroy Hood.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Baxter Ventures Deerfield, Illinois, United States
BlackSoil India, Maharashtra, Mumbai
China COSCO SHIPPING China, Shanghai
Cygnus Montanus Trust -
Everblu Capital Australia, New South Wales, Sydney
EXTOREL Bayern, Germany, Munich
HNA Capital Group -
Innovating Capital New York, New York, United States
Jiayi IEIG -
LongHash Ventures Central Region, Singapore, Singapore
Manufacturing Resources International Georgia, Louisiana, United States
Proterra Investment Partners Minneapolis, Minnesota, United States
Shanshui Capital Beijing, Beijing, China
SHIFT Japan, Tokyo
the Way Forward Aps -
UNT Group -
Vuzix New York, Rochester, United States
Whitehart Ventures California, United States, Venice
Zanichelli Venture Bologna, Emilia-Romagna, Italy

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Theraclone Sciences

Decision/Risk Analysis
Drug Delivery
Health Care
$4M03 Mar 2006 Seattle, Washington, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Institute for Systems Biology?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 10M
Rounds per year 0.14
Peak activity year 2003
Lead investments 0
Follow on index 0.33
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Theraclone Sciences

Decision/Risk Analysis
Drug Delivery
Health Care
$4M03 Mar 2006 Seattle, Washington, United States
Crunchbase icon

Content report

The following text will be sent to our editors: